ArrowMark Colorado Holdings’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q4 | – | Sell |
-18,082
| Closed | -$222K | – | 330 |
|
2017
Q3 | $222K | Sell |
18,082
-1,568
| -8% | -$19.3K | ﹤0.01% | 296 |
|
2017
Q2 | $225K | Sell |
19,650
-1,450
| -7% | -$16.6K | ﹤0.01% | 295 |
|
2017
Q1 | $439K | Buy |
21,100
+100
| +0.5% | +$2.08K | 0.01% | 270 |
|
2016
Q4 | $437K | Buy |
21,000
+468
| +2% | +$9.74K | 0.01% | 267 |
|
2016
Q3 | $673K | Hold |
20,532
| – | – | 0.01% | 241 |
|
2016
Q2 | $513K | Hold |
20,532
| – | – | 0.01% | 247 |
|
2016
Q1 | $503K | Sell |
20,532
-1,100
| -5% | -$26.9K | 0.01% | 239 |
|
2015
Q4 | $715K | Hold |
21,632
| – | – | 0.02% | 232 |
|
2015
Q3 | $709K | Sell |
21,632
-808
| -4% | -$26.5K | 0.02% | 236 |
|
2015
Q2 | $1.19M | Sell |
22,440
-4,810
| -18% | -$255K | 0.03% | 228 |
|
2015
Q1 | $786K | Buy |
+27,250
| New | +$786K | 0.02% | 226 |
|